Jennifer Jarrett, Chief Operating Officer at Arcus Biosciences, Inc. (RCUS), sold 43,042 shares at $17.76 ($764K) on 2023-12-22, disclosed to the SEC on 2023-12-26.
Scheduled sale ($764k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.76 | 21,521 | $382K | 50.0% |
| 2 | $17.76 | 21,521 | $382K | 50.0% |
| Total | $17.76 avg | 43,042 | $764K | 100% |
| Filing → |
| RCUS | SELL | 2025-10-08 | $1.3M | — | Filing → |
| RCUS | SELL | 2024-03-29 | $405K | — | Filing → |
| RCUS | SELL | 2024-03-20 | $458K | — | Filing → |